Spirulina is a blue-green algae sold as a whole-food protein and micronutrient source, and it is one of the older “superfood” ingredients still in steady demand. Brands abroad ask for it because it is a familiar name, is easy to combine with other greens or antioxidants, and is produced at scale in Japan.
This guide is for brand owners planning a spirulina product made in Japan. It covers what the human trials actually show, a quality-control issue specific to algae ingredients, how Japanese products are positioned, how spirulina is formulated, and what to fix before asking for a quotation.
Health supplements are foods, not medicines, and are not a substitute for medical treatment. Nothing here is a claim that any product prevents, treats or cures a disease.
💬 Planning a spirulina product made in Japan? We check the full formula against Japanese food law first. See Japan-made supplement OEM.
What the research shows
Meta-analyses report better lipid and blood-pressure markers with spirulina, but most trials enrolled adults who already had a metabolic condition, not healthy members of the general population.
| Study | Design/What was analysed | Reported result |
|---|---|---|
| Systematic review and dose-response meta-analysis, Pharmacological Research 2023;193:106802 (PMID 37263369) | 20 randomised controlled trials, 1,076 participants; effect of spirulina on LDL-C, total cholesterol, triglycerides and HDL-C | LDL-C, total cholesterol and triglycerides significantly reduced; HDL-C significantly increased |
| Systematic review and meta-analysis, Nutrients 2021;13(9):3054 (PMID 34578932, PMC8468496) | 5 RCTs (230 participants) for systolic blood pressure, 4 RCTs (214 participants) for diastolic blood pressure; participants included adults with hypertension, type 2 diabetes, chronic joint pain or ulcerative colitis; doses 1–8 g/day | Systolic blood pressure reduced by 4.59 mmHg on average; diastolic blood pressure reduced by 7.02 mmHg; the reduction was larger in the hypertensive subgroup than the normotensive subgroup |
| Systematic review and meta-analysis, Frontiers in Nutrition 2025;12:1624982 (PMID 40655486, PMC12245695) | 23 studies/28 trials, 1,035 overweight or obese adults, some with type 2 diabetes, hypertension, metabolic syndrome or ulcerative colitis; doses 0.02–10 g/day, most commonly 1–4 g/day | Spirulina alone improved body weight, total cholesterol, triglycerides, LDL-C, HDL-C and diastolic blood pressure; no significant effect on BMI, body fat, waist circumference, fasting glucose or insulin |
Three points to keep in view:
- Population. Most participants across these trials already had a diagnosed condition such as elevated lipids, high blood pressure or being overweight. None of the three reviews above studied healthy adults in the general population specifically for healthy-ageing outcomes.
- Certainty. The 2025 review rated the evidence for blood pressure and glucose-related outcomes as very low certainty (GRADE), and noted high heterogeneity between trials and mostly short intervention periods of 12 weeks or less.
- Funding. The 2021 blood-pressure review reported no external funding. The 2025 review was funded by university research grants and its authors declared no commercial conflict of interest.
Checked against the published abstracts on 25 September 2026.
What Japanese products say
Spirulina itself is sold in Japan as a general food, and a spirulina-derived ingredient was the basis of Japan’s first Foods with Function Claims notification of its kind for a skin-moisture function.
Under Japan’s Foods with Function Claims system, the notifying business is responsible for the scientific evidence behind its stated function and submits it to the Consumer Affairs Agency before sale. A phycocyanin ingredient derived from spirulina was notified for helping to keep skin moist by supporting the skin’s barrier function — a function of everyday skin condition, not a treatment.
Two lessons for a brand abroad:
- A notified function describes one purified fraction, not “spirulina” in general. The phycocyanin notification above applies to that specific ingredient and its tested amount, not to whole spirulina powder as a category.
- A Japanese notification is a Japanese regulatory mechanism for products sold in Japan. It is not a global endorsement, and it does not transfer automatically to your label abroad.
💬 Need an evidence summary for your regulatory adviser that separates independent meta-analyses from Japanese notifications? We prepare it with the manufacturing documents. Tell us your market.
Wording that stays on safe ground
Describe spirulina by its nutrient content and what has been studied in which population, not by conditions it would treat.
| Safer wording | Wording to avoid |
|---|---|
| ”A whole-food source of plant protein and micronutrients” | Disease names, or “treats”, “cures” or “prevents” anything |
| ”Studied for lipid and blood-pressure markers in adults with an existing condition” | Implying the same result for a healthy general-population user |
| ”Contains [X] mg spirulina per serving” with the source stated | ”Clinically proven” without naming the study, its population and its limits |
How spirulina is formulated
Spirulina is most often sold as tablets of pressed dried powder, because the effective amount is measured in grams rather than milligrams.
| Dosage form | Why brands choose it | What to weigh up |
|---|---|---|
| Tablet (pressed powder) | The most common format; several tablets deliver a gram-level daily amount | Taste and smell of raw algae; tablet size and count per dose |
| Hard capsule | Masks taste and smell better than a tablet | More capsules needed to reach a gram-level dose |
| Powder or powder stick | Flexible dosing, mixes into drinks and smoothies | Strong grassy taste and colour; stains |
Decisions that shape the specification:
- Source and cultivation. Spirulina for food is grown in open or closed ponds. Ask the supplier for its cultivation method and its cyanotoxin and heavy-metal testing programme.
- Amount per serving. Trial doses ranged from under 1 g/day to 10 g/day, with 1–4 g/day most common. Match the amount to any study you intend to cite, and to what the dosage form can practically deliver.
- Quality control for algae-specific contaminants. Because spirulina is grown in open water, it can carry microcystins — toxins produced by other cyanobacteria that sometimes grow alongside it — as well as heavy metals such as lead, arsenic, cadmium and mercury. A 2023 study of retail spirulina supplements and spirulina-containing foods found microcystins in every product tested (143–321 ng/g), with the highest concentrations in a spirulina powder and a spirulina tablet product. Testing for microcystins (commonly by ELISA or PCR-based methods) and for heavy metals (commonly by ICP-MS) on every batch, with a certificate of analysis, is the practical safeguard.
- Companion ingredients. Spirulina is often combined with other greens, antioxidants or plant extracts. Every ingredient in such a formula needs its own check against Japanese food law.
The check that comes first
Every ingredient must be permitted in foods in Japan, or a Japanese factory cannot make the product.
Spirulina itself is a long-established Japanese food ingredient. Combined “greens” or antioxidant formulas are where companion botanicals most often cause a problem, since some plant ingredients sold freely elsewhere are treated as medicines in Japan. See the Japan-made supplement OEM page, and compare with our green tea catechin and NMN guides if you are planning a combined healthy-ageing formula.
Before you ask for a quotation
A factory can quote accurately once the source, the amount, the form and the quality-control programme are fixed.
- Spirulina source and cultivation method
- Daily amount and servings per pack
- Dosage form
- Microcystin and heavy-metal testing requirements
- Companion ingredients and their amounts
- Packaging, and the countries you will sell in
💬 Ready to design a Japan-made spirulina product? Send us the concept — source, amount, form and the countries you will sell in.
Frequently asked questions
1. Does spirulina lower cholesterol or blood pressure?
Meta-analyses report improvements in lipid and blood-pressure markers, but most participants in the trials already had an existing condition such as elevated lipids or high blood pressure. Describe spirulina as studied in those populations rather than as a treatment.
2. Is spirulina safe for a healthy general-population product?
The reviews above were not designed to test general healthy-ageing benefits in people without an existing condition, so the evidence should not be stretched to cover that use.
3. What is the main quality-control risk specific to spirulina?
Because it is grown in open water, spirulina can carry microcystins from other cyanobacteria, along with heavy metals. A 2023 study found microcystins in every retail spirulina product it tested. Batch-by-batch testing is the standard safeguard.
4. Why is spirulina usually sold as a tablet?
The amount used in most trials is measured in grams, not milligrams, so a pressed-powder tablet is the most practical way to deliver a meaningful daily amount without an oversized capsule count.
5. What can stop a Japanese factory making my spirulina product?
Usually a companion botanical in a combined greens or antioxidant formula. Every ingredient must be permitted in foods in Japan, so we check the full formula first.
Sources: “The effect of Spirulina supplementation on lipid profile: GRADE-assessed systematic review and dose-response meta-analysis of data from randomized controlled trials”, Pharmacological Research 2023;193:106802 (PMID 37263369); “Effect of Spirulina Supplementation on Systolic and Diastolic Blood Pressure: Systematic Review and Meta-Analysis of Randomized Controlled Trials”, Nutrients 2021;13(9):3054 (PMID 34578932, PMC8468496); “Effects of spirulina supplementation alone or with exercise on cardiometabolic health in overweight and obese adults: a systematic review and meta-analysis”, Frontiers in Nutrition 2025;12:1624982 (PMID 40655486, PMC12245695); “Microbiota and Cyanotoxin Content of Retail Spirulina Supplements and Spirulina Supplemented Foods”, Microorganisms 2023;11(5):1175 (PMC10221061); Consumer Affairs Agency notifications for Foods with Function Claims. Checked on 12 October 2026.